SCHEMBL24735809

SCHEMBL24735809

CC(C)C(=O)N1[C@H](C)CCC[C@@H]1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.50
MGLL Q99685 1/20 0.48
ALDH1A1 P00352 4/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
ACE P12821 1/20 0.40
HSD11B1 P28845 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
RIPK1 Q13546 1/20 0.38
PHGDH O43175 1/20 0.37
ACHE P22303 1/20 0.37
KMT2A Q03164 3/20 0.37
DPP4 P27487 2/20 0.37
CHRNB2 P17787 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRNB3 Q05901 1/20 0.36
CHRNA6 Q15825 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13819922 0.91 PHGDH (0.44) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL13819923 0.91 PHGDH (0.44) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL14616989 0.91 PHGDH (0.44) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL17281555 0.83 RECQL (0.47) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL13733942 0.81 CHRNB2 (0.43) RECQLALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL24260118 0.80 RECQL (0.42) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL24260129 0.79 RECQL (0.38) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL24260122 0.79 RECQL (0.38) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL24260125 0.78 RECQL (0.37) RECQLMGLLALDH1A1GLAHPGD
SCHEMBL16866232 0.77 ALDH1A1 (0.45) RECQLMGLLALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278998-A1 Compound containing structure of a five-membered heteroaromatic ring, pharmaceutical compositions thereof and applications thereof 280 BIO, INC. (US) 2023-09-07 US disclosed
US-11530193-B2 Kinase inhibitors THE UNIVERSITY OF MANCHESTER (GB) 2022-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11530193-B2 Kinase inhibitors CAMKK2, CAMK1, CAMKK1 RECQL 4644/4885MGLL 4778/4885ALDH1A1 2394/4885
US-20230278998-A1 Compound containing structure of a five-membered heteroaromatic ring, pharmaceutical compositions thereof and applications thereof PARG, CYP3A5, CYP11B1 RECQL 453/4885MGLL 1687/4885ALDH1A1 749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.